Literature DB >> 8862347

Sarcoidosis and common variable immunodeficiency. Report of 8 cases and review of the literature.

M B Fasano1, K E Sullivan, S B Sarpong, R A Wood, S M Jones, C J Johns, H M Lederman, M J Bykowsky, J M Greene, J A Winkelstein.   

Abstract

The true incidence of sarcoidosis in common variable immunodeficiency (CVID) is unknown. We report here 8 cases of sarcoidosis among 80 patients with CVID followed in our clinics, along with 22 well-documented cases reported in the literature. Sarcoidosis, therefore, represents an important entity to consider among patients with CVID who exhibit clinical, radiographic, laboratory, and biopsy findings compatible with sarcoidosis. Conversely, the diagnosis of CVID should be considered in patients with sarcoidosis who do not exhibit the characteristic hypergammaglobulinemia and who have a history of recurrent infections. Although many features of sarcoidosis are similar in patients with CVID to those in patients with sarcoidosis alone, there are many important differences. Patients with CVID in whom sarcoidosis develops present with hypogammaglobulinemia rather than hypergammaglobulinemia and have a higher prevalence of recurrent infections, thrombocytopenia, and splenic involvement. Steroids, in most cases, appeared helpful in reducing adenopathy and splenomegaly, improving uveitis, lowering serum alkaline phosphatase, and reversing hematologic abnormalities. The underlying pathophysiology responsible for the association of these 2 disorders in the same patient remains obscure. However, as more patients are identified, it may be possible to gain a better understanding of the immunologic defect responsible for the dual presentation of these 2 relatively uncommon diseases.

Entities:  

Mesh:

Year:  1996        PMID: 8862347     DOI: 10.1097/00005792-199609000-00002

Source DB:  PubMed          Journal:  Medicine (Baltimore)        ISSN: 0025-7974            Impact factor:   1.889


  39 in total

1.  International Consensus Document (ICON): Common Variable Immunodeficiency Disorders.

Authors:  Francisco A Bonilla; Isil Barlan; Helen Chapel; Beatriz T Costa-Carvalho; Charlotte Cunningham-Rundles; M Teresa de la Morena; Francisco J Espinosa-Rosales; Lennart Hammarström; Shigeaki Nonoyama; Isabella Quinti; John M Routes; Mimi L K Tang; Klaus Warnatz
Journal:  J Allergy Clin Immunol Pract       Date:  2015-11-07

2.  Profound Reversible Hypogammaglobulinemia Caused by Celiac Disease in the Absence of Protein Losing Enteropathy.

Authors:  Rohan Ameratunga; Russell William Barker; Richard Henderson Steele; Maneka Deo; See-Tarn Woon; Mee Ling Yeong; Wikke Koopmans
Journal:  J Clin Immunol       Date:  2015-08-29       Impact factor: 8.317

Review 3.  How I treat common variable immune deficiency.

Authors:  Charlotte Cunningham-Rundles
Journal:  Blood       Date:  2010-03-23       Impact factor: 22.113

Review 4.  Common variable immune deficiency: reviews, continued puzzles, and a new registry.

Authors:  Charlotte Cunningham-Rundles; Adina Kay Knight
Journal:  Immunol Res       Date:  2007       Impact factor: 2.829

5.  Common variable immunodeficiency-associated myelitis: report of treatment with infliximab.

Authors:  N Kumar; J B Hagan; R S Abraham; A J Aksamit
Journal:  J Neurol       Date:  2008-07-21       Impact factor: 4.849

6.  Granulomatous disease: distinguishing primary antibody disease from sarcoidosis.

Authors:  D F Arnold; J Wiggins; C Cunningham-Rundles; S A Misbah; H M Chapel
Journal:  Clin Immunol       Date:  2008-05-16       Impact factor: 3.969

Review 7.  Immunodeficiencies.

Authors:  M Ballow; L Notarangelo; B Grimbacher; C Cunningham-Rundles; M Stein; M Helbert; B Gathmann; G Kindle; A K Knight; H D Ochs; K Sullivan; J L Franco
Journal:  Clin Exp Immunol       Date:  2009-12       Impact factor: 4.330

Review 8.  Development of granulomatous common variable immunodeficiency subsequent to infection with Toxoplasma gondii.

Authors:  S Mrusek; A Marx; J Kummerle-Deschner; N Tzaribachev; A Enders; U-N Riede; K Warnatz; G E Dannecker; S Ehl
Journal:  Clin Exp Immunol       Date:  2004-09       Impact factor: 4.330

9.  Outcomes of splenectomy in patients with common variable immunodeficiency (CVID): a survey of 45 patients.

Authors:  G K Wong; S Goldacker; C Winterhalter; B Grimbacher; H Chapel; M Lucas; D Alecsandru; D McEwen; I Quinti; H Martini; C Milito; R E Schmidt; D Ernst; T Espanol; A Vidaller; J Carbone; E Fernandez-Cruz; V Lougaris; A Plebani; N Kutukculer; L I Gonzalez-Granado; R Contreras; S Kiani-Alikhan; M A A Ibrahim; J Litzman; A Jones; H B Gaspar; L Hammarstrom; U Baumann; K Warnatz; A P Huissoon
Journal:  Clin Exp Immunol       Date:  2013-04       Impact factor: 4.330

10.  A case of granulomatous lung disease in a patient with Good's syndrome.

Authors:  Seung Heon Lee; Sang Min Lee; Seok Chul Yang; Chul Gyu Yoo; Young Whan Kim; Young Soo Shim; Sung Koo Han
Journal:  Korean J Intern Med       Date:  2008-12       Impact factor: 3.165

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.